Winner Medical Co., Ltd. (300888.SZ)
CNY 44.54
(0.09%)
CNY 44.54
(0.09%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.86 Billion CNY | -9.92% |
| 2022 | 3.18 Billion CNY | 17.76% |
| 2021 | 2.7 Billion CNY | 9.51% |
| 2020 | 2.46 Billion CNY | 43.14% |
| 2019 | 1.72 Billion CNY | 27.47% |
| 2018 | 1.35 Billion CNY | 22.17% |
| 2017 | 1.1 Billion CNY | 49.1% |
| 2016 | 743.13 Million CNY | 49.85% |
| 2015 | 495.92 Million CNY | 44.8% |
| 2014 | 342.48 Million CNY | 28.93% |
| 2013 | 265.64 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 728.42 Million CNY | -32.91% |
| 2024 Q3 | 769.54 Million CNY | 1.32% |
| 2024 Q2 | 737.37 Million CNY | 1.23% |
| 2023 Q1 | 729.62 Million CNY | -20.61% |
| 2023 Q4 | 1.08 Billion CNY | 57.4% |
| 2023 FY | 2.86 Billion CNY | -9.92% |
| 2023 Q3 | 689.8 Million CNY | -2.25% |
| 2023 Q2 | 705.71 Million CNY | -3.28% |
| 2022 Q4 | 918.98 Million CNY | 24.27% |
| 2022 Q3 | 739.48 Million CNY | -10.83% |
| 2022 Q2 | 829.3 Million CNY | 18.93% |
| 2022 Q1 | 697.31 Million CNY | -31.35% |
| 2022 FY | 3.18 Billion CNY | 17.76% |
| 2021 FY | 2.7 Billion CNY | 9.51% |
| 2021 Q3 | 416.16 Million CNY | -32.66% |
| 2021 Q4 | 1.01 Billion CNY | 144.09% |
| 2021 Q1 | 654.75 Million CNY | 42.09% |
| 2021 Q2 | 618.01 Million CNY | -5.61% |
| 2020 Q2 | 711.93 Million CNY | 70.49% |
| 2020 FY | 2.46 Billion CNY | 43.14% |
| 2020 Q1 | 417.59 Million CNY | -24.67% |
| 2020 Q3 | 879.45 Million CNY | 23.53% |
| 2020 Q4 | 460.79 Million CNY | -47.6% |
| 2019 Q4 | 554.36 Million CNY | 36.73% |
| 2019 FY | 1.72 Billion CNY | 27.47% |
| 2019 Q3 | 405.44 Million CNY | 5.36% |
| 2019 Q2 | 384.82 Million CNY | 0.0% |
| 2019 Q1 | 384.82 Million CNY | 0.0% |
| 2018 FY | 1.35 Billion CNY | 22.17% |
| 2017 FY | 1.1 Billion CNY | 49.1% |
| 2016 FY | 743.13 Million CNY | 49.85% |
| 2015 FY | 495.92 Million CNY | 44.8% |
| 2014 FY | 342.48 Million CNY | 28.93% |
| 2013 FY | 265.64 Million CNY | 0.0% |